drugset / Trial / NCT00430937
Efficacy and Safety of Daptomycin Versus Vancomycin or Teicoplanin for Treatment of Complicated Skin and Soft Tissue Infections
RandomizedParallel-groupSingle-blindTreatment
Summary
This study evaluated the efficacy and safety of daptomycin compared to vancomycin or teicoplanin for the treatment of complicated skin and soft tissue infections
Timeline
- Start
- 2006-04
- Primary completion
- 2008-03
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Daptomycin | Other / unclassified | 4 mg/kg | Intravenous |
| Comparator | Teicoplanin | Other / unclassified | 400 mg | Intravenous |
| Comparator | Vancomycin | Other / unclassified | 1 g | Intravenous |